Skip Navigation
left arrowGo back to In the News Page

Winning the Decade: A Conversation with Jason Hall, CEO Greater St. Louis, Inc.

March 28, 2024

about_landing-page-outside-of-4240_2500.jpeg

Winning the Decade: A Conversation with Jason Hall, CEO Greater St. Louis, Inc.

Originally Published by The New Localism By Bruce Katz

A consistent focus of this newsletter has been the pandemic and other disruptive forces that have followed in its wake that have the potential to reshuffle the order of successful cities. As I’ve written before: “For cities that are organized, deliberate and purposeful, there is the tantalizing prospect of using this period to leapfrog, diversifying and greening their economies to become more economically resilient, socially inclusive and environmentally sustainable.”

St. Louis may be one of those metropolitan areas.

One of the distinguishing factors of economic development in U.S. cities and metros is the powerful leadership exercised by the private and civic sectors. As Jeremy Nowak and I observed in The New Localism, “The rise of CEO-led general-purpose and special-purpose corporations represents a structural shift in the role of business and civic leaders in U.S. cities.” That has come to the fore during this period of transformative economic restructuring, as the metros that are able to capitalize on this moment, such as Columbus, Syracuse, and St. Louis, have strong, well-resourced, business/civic leadership groups.

Read the full article on The New Localism below. 

More Articles

download.webp

St. Louis wants to turbocharge its neuroscience...

NEURO360 — a $160 million grant proposal that regional leaders and academics hope will turbocharge the local neuroscience sector — is led by the staff...

arrow pointing right
Downtown_from_Lafeyette.webp

Welcoming Growth

Newly released data from the U.S. Census Bureau shows that efforts to increase the St. Louis metro’s immigrant population are succeeding.

arrow pointing right
91a9887_320x480x4237-6374-0-346.jpg

St. Louis-based cancer drug company launches...

St. Louis biotech company Immunophotonics is testing its drug to enhance a cancer treatment in collaboration with the Cardiovascular and Interventional...

arrow pointing right
fancy footer design